Cargando…
Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study
BACKGROUND: Our aim was to compare the 12-month incidence and clearance of oral high-risk HPV infection between HIV-infected men who have sex with men (MSM) and HIV-negative MSM. METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands. Questionnaire data and oral-rinse and g...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299566/ https://www.ncbi.nlm.nih.gov/pubmed/25551194 http://dx.doi.org/10.1186/s12879-014-0668-z |
_version_ | 1782353420335710208 |
---|---|
author | van Aar, Fleur Mooij, Sofie H van der Sande, Marianne AB Meijer, Chris JLM King, Audrey J Verhagen, Dominique WM Heijman, Titia Coutinho, Roel A Schim van der Loeff, Maarten F |
author_facet | van Aar, Fleur Mooij, Sofie H van der Sande, Marianne AB Meijer, Chris JLM King, Audrey J Verhagen, Dominique WM Heijman, Titia Coutinho, Roel A Schim van der Loeff, Maarten F |
author_sort | van Aar, Fleur |
collection | PubMed |
description | BACKGROUND: Our aim was to compare the 12-month incidence and clearance of oral high-risk HPV infection between HIV-infected men who have sex with men (MSM) and HIV-negative MSM. METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands. Questionnaire data and oral-rinse and gargle samples were collected at baseline, and after 6 and 12 months. HPV DNA was genotyped using the SPF(10)-PCR & DEIA-LiPA(25) system (version 1). Determinants of oral HPV incidence and clearance were explored using Cox and logistic regression analyses respectively. RESULTS: 433 HIV-negative and 290 HIV-infected MSM were included in these analyses. The median follow-up time per participant was 12 months (range 3–15). During follow-up, 114 incident oral high-risk HPV infections were observed. The incidence rate of HPV-16 was 3.5/1000 person-months (PM) in HIV-infected and 0.9/1000 PM in HIV-negative MSM (IRR 4.1; 95% CI 1.3-13.2). The incidence rates of other high-risk HPV types ranged between 1.3-3.5/1000 PM in HIV-infected and 0.0-1.1/1000 PM in HIV-negative MSM. In multivariable analyses, HIV infection (adjusted hazard ratio [aHR] 3.8; 95% CI 2.3-6.2) and a higher number of recent oral sex partners (aHR 2.4 for ≥8 partners compared to ≤2; 95% CI 1.4-4.2) were associated with HPV incidence. Of the 111 baseline oral high-risk infections, 59 (53.2%) were cleared. In multivariable analyses, only a higher number of recent oral sex partners was associated with HPV clearance (adjusted odds ratio 3.4 for ≥8 compared to ≤2 partners; 95% CI 1.3-9.0). CONCLUSIONS: The incidence rate of oral high-risk HPV infection was higher in HIV-infected MSM and in those with a higher number of recent oral sex partners. Just over half of the oral high-risk HPV infections at baseline were cleared after 12 months, with a higher likelihood of clearance among MSM reporting higher numbers of recent oral sex partners, but no difference by HIV status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0668-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4299566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42995662015-01-21 Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study van Aar, Fleur Mooij, Sofie H van der Sande, Marianne AB Meijer, Chris JLM King, Audrey J Verhagen, Dominique WM Heijman, Titia Coutinho, Roel A Schim van der Loeff, Maarten F BMC Infect Dis Research Article BACKGROUND: Our aim was to compare the 12-month incidence and clearance of oral high-risk HPV infection between HIV-infected men who have sex with men (MSM) and HIV-negative MSM. METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands. Questionnaire data and oral-rinse and gargle samples were collected at baseline, and after 6 and 12 months. HPV DNA was genotyped using the SPF(10)-PCR & DEIA-LiPA(25) system (version 1). Determinants of oral HPV incidence and clearance were explored using Cox and logistic regression analyses respectively. RESULTS: 433 HIV-negative and 290 HIV-infected MSM were included in these analyses. The median follow-up time per participant was 12 months (range 3–15). During follow-up, 114 incident oral high-risk HPV infections were observed. The incidence rate of HPV-16 was 3.5/1000 person-months (PM) in HIV-infected and 0.9/1000 PM in HIV-negative MSM (IRR 4.1; 95% CI 1.3-13.2). The incidence rates of other high-risk HPV types ranged between 1.3-3.5/1000 PM in HIV-infected and 0.0-1.1/1000 PM in HIV-negative MSM. In multivariable analyses, HIV infection (adjusted hazard ratio [aHR] 3.8; 95% CI 2.3-6.2) and a higher number of recent oral sex partners (aHR 2.4 for ≥8 partners compared to ≤2; 95% CI 1.4-4.2) were associated with HPV incidence. Of the 111 baseline oral high-risk infections, 59 (53.2%) were cleared. In multivariable analyses, only a higher number of recent oral sex partners was associated with HPV clearance (adjusted odds ratio 3.4 for ≥8 compared to ≤2 partners; 95% CI 1.3-9.0). CONCLUSIONS: The incidence rate of oral high-risk HPV infection was higher in HIV-infected MSM and in those with a higher number of recent oral sex partners. Just over half of the oral high-risk HPV infections at baseline were cleared after 12 months, with a higher likelihood of clearance among MSM reporting higher numbers of recent oral sex partners, but no difference by HIV status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0668-z) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-31 /pmc/articles/PMC4299566/ /pubmed/25551194 http://dx.doi.org/10.1186/s12879-014-0668-z Text en © van Aar et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article van Aar, Fleur Mooij, Sofie H van der Sande, Marianne AB Meijer, Chris JLM King, Audrey J Verhagen, Dominique WM Heijman, Titia Coutinho, Roel A Schim van der Loeff, Maarten F Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title_full | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title_fullStr | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title_full_unstemmed | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title_short | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
title_sort | twelve-month incidence and clearance of oral hpv infection in hiv-negative and hiv-infected men who have sex with men: the h2m cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299566/ https://www.ncbi.nlm.nih.gov/pubmed/25551194 http://dx.doi.org/10.1186/s12879-014-0668-z |
work_keys_str_mv | AT vanaarfleur twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT mooijsofieh twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT vandersandemarianneab twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT meijerchrisjlm twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT kingaudreyj twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT verhagendominiquewm twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT heijmantitia twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT coutinhoroela twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy AT schimvanderloeffmaartenf twelvemonthincidenceandclearanceoforalhpvinfectioninhivnegativeandhivinfectedmenwhohavesexwithmentheh2mcohortstudy |